Claims
- 1. A method of treating multi-drug resistance which comprises administering to a patient suffering therefrom an effective amount of a compound selected from the group consisting of compounds of the formula: ##STR13## where A=phenyl (unsubstituted, mono- or multi-halogen substituted), H or C.sub.1 -C.sub.3 -alkyl, 2-furyl or 2-thienyl and R- is ##STR14## with Y=phenylalkyl or fluorphenyl alkyl as well as all physiological acceptable acid addition salts thereof, the compound of Formula II ##STR15## a compound of Formula III ##STR16## and flezelastine and its optical isomers.
- 2. A method of treating multi-drug resistance as set forth in claim 1 wherein the compound administered is the compound of Formula I.
- 3. A method of treating multi-drug resistance as set forth in claim 1 wherein the compound administered is the compound of Formula II.
- 4. A method of treating multi-drug resistance as set forth in claim 1 wherein the compound administered is the compound of Formula III.
- 5. A method of treating multi-drug resistance as set forth in claim 1 wherein the compound administered is selected from the group consisting of flezelastin and its optical isomers.
Priority Claims (1)
Number |
Date |
Country |
Kind |
42 33 113.7 |
Oct 1992 |
DEX |
|
Parent Case Info
This is a continuation of application Ser. No. 08/154,091, filed on Nov. 18, 1993, which was abandoned upon the filing hereof which is a continuation of Ser. No. 08/124,496, filed Sep. 22, 1993, now abandoned.
Non-Patent Literature Citations (1)
Entry |
Chemical Abstracts 112:132033d, Yamanoto et al., 1989. |
Continuations (2)
|
Number |
Date |
Country |
Parent |
154091 |
Nov 1993 |
|
Parent |
124496 |
Sep 1993 |
|